IDO1 and depressive symptom measurement: To our surprise, 1-MT, an IDO inhibitor known to exert its antidepressant effect through competitively inhibiting IDO activity and reducing the production of Kyn pathway metabolites, showed a similar antidepressant effect in HFD-induced depression.